Cargando…

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections

BACKGROUND: Despite the high level of protection against severe COVID-19 provided by the currently available vaccines some breakthrough infections occur. Until now, there is no information whether a potential risk of a breakthrough infection can be inferred from the level of antibodies after booster...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möhlendick, Birte, Čiučiulkaitė, Ieva, Elsner, Carina, Anastasiou, Olympia E., Trilling, Mirko, Wagner, Bernd, Zwanziger, Denise, Jöckel, Karl-Heinz, Dittmer, Ulf, Siffert, Winfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260040/ https://www.ncbi.nlm.nih.gov/pubmed/35812411 http://dx.doi.org/10.3389/fimmu.2022.907343

Ejemplares similares

GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
por: Čiučiulkaitė, Ieva, et al.
Publicado: (2022)

Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in IFITM3 on the Antibody Response after Vaccination against COVID-19
por: Čiučiulkaitė, Ieva, et al.
Publicado: (2023)

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022)

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19
por: Schönfelder, Kristina, et al.
Publicado: (2021)

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study
por: Schönfelder, Kristina, et al.
Publicado: (2021)

The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
por: Möhlendick, Birte, et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19
por: Krempe, Friederike, et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

A simple algorithm based on initial Ct values predicts the duration to SARS-CoV-2 negativity and allows more efficient test-to-release and return-to-work schedules
por: Anastasiou, Olympia E., et al.
Publicado: (2023)

Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center
por: Buechter, Matthias, et al.
Publicado: (2023)

Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations
por: Klingen, Robin L., et al.
Publicado: (2021)

Development of De Novo Donor-specific HLA Antibodies and AMR in Renal Transplant Patients Depends on CYP3A5 Genotype
por: Friebus-Kardash, Justa, et al.
Publicado: (2021)

GNB3 c.825C>T (rs5443) Polymorphism and Risk of Acute Cardiovascular Events after Renal Allograft Transplant
por: Peitz, Tobias, et al.
Publicado: (2022)

CC Genotype of GNAS c.393C>T (rs7121) Polymorphism Has a Protective Effect against Development of BK Viremia and BKV-Associated Nephropathy after Renal Transplant
por: Peitz, Tobias, et al.
Publicado: (2022)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

Single-Nucleotide Polymorphism in Genes Encoding G Protein Subunits GNB3 and GNAQ Increase the Risk of Cardiovascular Morbidity among Patients Undergoing Renal Replacement Therapy
por: Birkner, Simon, et al.
Publicado: (2023)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19
por: Möhlendick, Birte, et al.
Publicado: (2021)

Weaker is better
por: Nyberg, Kara A.
Publicado: (2005)

The Weaker Sex
por: Hess, Sharon Folkenroth
Publicado: (2022)

Weaker together or weaker apart? Great power relations after the coronavirus
por: Biscop, Sven
Publicado: (2020)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
por: Pradenas, Edwards, et al.
Publicado: (2023)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
por: Pérez-Alós, Laura, et al.
Publicado: (2023)

Our Weaker Brethren
Publicado: (1893)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers
por: Willuweit, Katharina, et al.
Publicado: (2022)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
por: Wei, Jia, et al.
Publicado: (2023)

On weaker forces than gravity
por: De Rújula, Alvaro
Publicado: (1986)

Weaker neural suppression in autism
por: Schallmo, Michael-Paul, et al.
Publicado: (2020)

Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients
por: Passenberg, Moritz, et al.
Publicado: (2023)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Seasonality of Non-SARS, Non-MERS Coronaviruses and the Impact of Meteorological Factors
por: Anastasiou, Olympia E., et al.
Publicado: (2021)

Case Marking in Hindi as the Weaker Language
por: Montrul, Silvina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a6i5m5ibmmnfho5n81f9f0r7cc